Brain imaging for the vasopressin V1A receptor linked to autism

PET ligand discovery for arginine vasopressin

NIH-funded research Emory University · NIH-11357648

Creating a new PET tracer to see vasopressin V1A receptors in the brains of people with autism.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11357648 on NIH RePORTER

What this research studies

This project aims to produce a PET imaging tracer that specifically binds the V1A vasopressin receptor, a protein associated with autism. The team will chemically modify and test candidate compounds, building on an earlier selective ligand that had poor brain uptake. Promising tracers will be screened in animals and higher species for safety and brain penetration before the top candidate is prepared for human imaging. Human PET scans would map V1A receptor distribution and help measure whether V1A-targeted drugs reach their target in living brains.

Who could benefit from this research

Good fit: Ideal candidates would include adults with autism spectrum disorder who can safely undergo PET imaging and possibly healthy volunteers for comparison.

Not a fit: People who cannot tolerate PET scans, are pregnant, or whose condition is unlikely linked to vasopressin signaling may not receive direct benefit.

Why it matters

Potential benefit: If successful, this could let clinicians and researchers see V1A receptor levels in living brains, improving understanding of autism and speeding development of targeted treatments.

How similar studies have performed: To date no V1A-specific PET tracer has been successful for human use, although earlier compounds were selective but lacked sufficient brain penetration.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autism Spectrum Disorder patient
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.